Osteoporosis in chronic kidney disease: diagnostic dilemmas and therapeutic controversies
In the absence of evidence-based treatment protocols for CKD-associated osteoporosis, fracture prevention should rely on pragmatic individualized risk assessment. Optimization of mineral metabolism and cautious use of bone-targeting therapies in high-risk patients are key components of management strategy. Future studies should prioritize CKD-specific fracture outcomes and validated diagnostic strategies to guide treatment decisions.
Authors
- Marie Houmaa Vrist (ORCID: https://orcid.org/0000-0002-5556-0078)
- Hanne Skou Jørgensen (ORCID: https://orcid.org/0000-0002-0881-2615)
- Bente Langdahl (ORCID: https://orcid.org/0000-0002-8712-7199)
- S. Sakthivel
Institutions
- Aarhus University (DK)
- Aarhus University Hospital (DK)
- University Clinic for Nephrology and Hypertension, Diabetology and Endocrinology (DE)
Publication Details
- Journal
- Expert Review of Endocrinology & Metabolism
- Published
- 2026-03-17
- DOI
- https://doi.org/10.1080/17446651.2026.2646161
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00